by Gary Chandler | Feb 16, 2020 | Alzheimer's Disease Statistics
Prevention Requires Truth Alzheimer disease (AD) is the most common dementia in the elderly and is a growing epidemic across the globe. Although the risks associated with developing AD are numerous, the greatest risk factor by far is aging. The age-specific risk of AD...
by Gary Chandler | Nov 5, 2019 | Alzheimer's Disease Treatment
Drug Targets Brain And Microbiome China has granted conditional approval to an Alzheimer’s disease drug that is derived from seaweed, potentially shaking up the field after years of clinical failures involving experimental therapies from major drug...
by Gary Chandler | Oct 5, 2019 | Alzheimer's Disease Research
No Effective Prevention, Treatment It has been a big week for Alzheimer’s disease research with large grants being awarded to multiple organizations, and a private donation of $50 million going to the University of Washington Medicine. A portion of the Federal...
by Gary Chandler | Sep 5, 2019 | Alzheimer's Disease Research
Clinical Trials Failing But Knowledge Advancing By Kendall Powell, Science After some costly and disappointing drug trial failures, the field welcomes a funding surge, tools for tracking disease, and interdisciplinary collaborations to tackle one of science’s most...
by Gary Chandler | Dec 7, 2016 | Alzheimer's Disease Diagnosis
Earlier Treatment Generates Better Outcomes Researchers from Aberdeen have identified changes in the brains of those suffering early signs of Alzheimer’s disease. A University of Aberdeen study confirmed for the first time that two proteins, assumed to...
